Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iranian traditional medicine syrup versus solifenacin for urgency urinary incontinence in women
IRCT20251110067942N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of solifenacin in urge incontinence (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Number of daytime urinations, Amount and volume of involuntary urine leakage and 1 more. Started Dec 2025; status: completed.
02
Drugs
solifenacin
03
Conditions
urge incontinence
Beyond the preview
Go deeper on IRCT20251110067942N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251110067942N1.